Reduction of neurologic injury after high-risk thoracoabdominal aortic operation

Ann Thorac Surg. 1998 Jul;66(1):132-8. doi: 10.1016/s0003-4975(98)00359-2.

Abstract

Background: Of all aortic operations, thoracoabdominal aortic repairs have the highest risk of spinal cord neurologic injury, manifest by lower limb paraplegia or paraparesis. Cerebrospinal fluid drainage combined with intrathecal papaverine (CSFDr + IP) may reduce the risk and severity of neurologic injury. The objective of this study was to evaluate the effect of CSFDr + IP to prevent neurologic injury after high-risk thoracoabdominal aneurysm repairs.

Methods: We screened 64 patients before operation with descending thoracic or thoracoabdominal aneurysms for possible inclusion in a prospective, randomized study. Thirty-three patients with high-risk type I and II thoracoabdominal aneurysms met inclusion criteria and 17 were randomly assigned to CSFDr + IP and 16 to the control group. The study was terminated early after interim analysis revealed a significant difference.

Results: Of 64 patients screened, 2 patients died after operation (3.1%, 2/64); both were in the randomized study (6%, 2/33), and neither had a neurologic injury. Neurologic injury developed in 2 CSFDr + IP patients and 7 control patients (p = 0.0392). Control patients also had lower postoperative motor strength scores (p = 0.0340). On multivariate analysis, risk factors for neurologic injury included (p < 0.05) longer cross-clamp time, failure to actively cool with bypass, and postoperative hypotension, whereas CSFDr + IP was protective. Logistic regression showed that CSFDr + IP and active cooling significantly reduced the risk of injury and that the two combined modalities were additive. Of 64 patients screened, only 2 (3%) had a permanent neurologic deficit preventing ambulation.

Conclusions: For high-risk thoracoabdominal aneurysms, CSFDr + IP was effective in reducing the incidence and severity of neurologic injury. Active cooling may be further additive to CSFDr + IP protection, although this needs to be confirmed in a larger study.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Aortic Aneurysm, Abdominal / surgery*
  • Aortic Aneurysm, Thoracic / surgery*
  • Cardiopulmonary Bypass
  • Cerebrospinal Fluid
  • Drainage
  • Female
  • Humans
  • Hypotension / etiology
  • Hypothermia, Induced
  • Injections, Spinal
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Muscle Contraction / physiology
  • Neuroprotective Agents / administration & dosage
  • Neuroprotective Agents / therapeutic use
  • Papaverine / administration & dosage
  • Papaverine / therapeutic use
  • Paraplegia / prevention & control*
  • Paresis / prevention & control*
  • Prospective Studies
  • Risk Factors
  • Spinal Cord / physiopathology
  • Survival Rate
  • Time Factors
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use

Substances

  • Neuroprotective Agents
  • Vasodilator Agents
  • Papaverine